Figure 2 | British Journal of Cancer

Figure 2

From: Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients

Figure 2

Kaplan–Meier plots for overall survival indicating randomisation to 2 years of tamoxifen treatment contra no treatment. (A) Overview of the entire cohort including both ERα positive and negative tumours. (B) The subgroup of 101 >90% ERα positive breast cancer samples. (C, D) Overall survival for patients having tumours with >90% ERα positivity in relation to cyclin D1 intensity (low/moderate or high expression). P-values are presented in a box with values at 10 years of follow-up (22 years of follow-up in parenthesis).

Back to article page